Rank | Gene Set | Z-score |
---|---|---|
1 | muscle filament sliding (GO:0030049) | 9.58591841 |
2 | actin-myosin filament sliding (GO:0033275) | 9.58591841 |
3 | regulation of skeletal muscle contraction (GO:0014819) | 9.22351618 |
4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.57436822 |
5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 8.13302317 |
6 | sarcomere organization (GO:0045214) | 8.02366226 |
7 | actin-mediated cell contraction (GO:0070252) | 7.92666141 |
8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 7.44844098 |
9 | skeletal muscle contraction (GO:0003009) | 7.08235985 |
10 | myofibril assembly (GO:0030239) | 7.05245893 |
11 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.03204222 |
12 | skeletal muscle adaptation (GO:0043501) | 6.52180117 |
13 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 6.42828418 |
14 | cardiac myofibril assembly (GO:0055003) | 6.41592687 |
15 | regulation of cell communication by electrical coupling (GO:0010649) | 6.40681528 |
16 | regulation of relaxation of muscle (GO:1901077) | 6.34783636 |
17 | carnitine shuttle (GO:0006853) | 6.34668689 |
18 | plasma membrane repair (GO:0001778) | 6.31034766 |
19 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.15078744 |
20 | striated muscle contraction (GO:0006941) | 6.06315381 |
21 | tricarboxylic acid cycle (GO:0006099) | 5.93481045 |
22 | actin filament-based movement (GO:0030048) | 5.92570593 |
23 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.92239791 |
24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.85812726 |
25 | cardiac muscle contraction (GO:0060048) | 5.71179588 |
26 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.70313883 |
27 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.60934135 |
28 | fatty acid transmembrane transport (GO:1902001) | 5.58081312 |
29 | creatine metabolic process (GO:0006600) | 5.45931593 |
30 | actomyosin structure organization (GO:0031032) | 5.28045451 |
31 | regulation of actin filament-based movement (GO:1903115) | 5.23680168 |
32 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.15850313 |
33 | regulation of cofactor metabolic process (GO:0051193) | 5.09090481 |
34 | regulation of coenzyme metabolic process (GO:0051196) | 5.09090481 |
35 | cardiac muscle cell development (GO:0055013) | 4.90822894 |
36 | glycogen catabolic process (GO:0005980) | 4.89479895 |
37 | carnitine transmembrane transport (GO:1902603) | 4.71240901 |
38 | cardiac muscle hypertrophy (GO:0003300) | 4.64076493 |
39 | muscle contraction (GO:0006936) | 4.59987644 |
40 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.59633446 |
41 | striated muscle atrophy (GO:0014891) | 4.59024053 |
42 | cardiac cell development (GO:0055006) | 4.59008351 |
43 | striated muscle hypertrophy (GO:0014897) | 4.57702848 |
44 | glucan catabolic process (GO:0009251) | 4.57425826 |
45 | regulation of sarcomere organization (GO:0060297) | 4.54801197 |
46 | response to inactivity (GO:0014854) | 4.54489465 |
47 | regulation of striated muscle contraction (GO:0006942) | 4.54104257 |
48 | response to muscle activity (GO:0014850) | 4.52110172 |
49 | skeletal muscle tissue development (GO:0007519) | 4.51507607 |
50 | striated muscle adaptation (GO:0014888) | 4.45799939 |
51 | heart process (GO:0003015) | 4.39614225 |
52 | heart contraction (GO:0060047) | 4.39614225 |
53 | amino-acid betaine transport (GO:0015838) | 4.29885014 |
54 | carnitine transport (GO:0015879) | 4.29885014 |
55 | cellular polysaccharide catabolic process (GO:0044247) | 4.27592756 |
56 | muscle system process (GO:0003012) | 4.22269891 |
57 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.18253366 |
58 | regulation of sulfur metabolic process (GO:0042762) | 4.16968966 |
59 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.12005978 |
60 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.11257473 |
61 | skeletal muscle fiber development (GO:0048741) | 4.10812964 |
62 | skeletal muscle tissue regeneration (GO:0043403) | 4.07464098 |
63 | polysaccharide catabolic process (GO:0000272) | 4.05262778 |
64 | regulation of the force of heart contraction (GO:0002026) | 4.04663880 |
65 | muscle hypertrophy (GO:0014896) | 4.03904213 |
66 | regulation of membrane repolarization (GO:0060306) | 4.03020875 |
67 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.02210092 |
68 | glucan biosynthetic process (GO:0009250) | 4.01779976 |
69 | glycogen biosynthetic process (GO:0005978) | 4.01779976 |
70 | muscle atrophy (GO:0014889) | 3.95989152 |
71 | muscle fiber development (GO:0048747) | 3.91184208 |
72 | muscle tissue morphogenesis (GO:0060415) | 3.90322239 |
73 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.85825865 |
74 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.85811465 |
75 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.85811465 |
76 | cytidine deamination (GO:0009972) | 3.81360769 |
77 | cytidine metabolic process (GO:0046087) | 3.81360769 |
78 | cytidine catabolic process (GO:0006216) | 3.81360769 |
79 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.77005925 |
80 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.77005925 |
81 | relaxation of muscle (GO:0090075) | 3.75615128 |
82 | striated muscle cell development (GO:0055002) | 3.74108993 |
83 | 2-oxoglutarate metabolic process (GO:0006103) | 3.73153673 |
84 | muscle structure development (GO:0061061) | 3.67821090 |
85 | myotube cell development (GO:0014904) | 3.66763918 |
86 | muscle adaptation (GO:0043500) | 3.66178034 |
87 | muscle organ development (GO:0007517) | 3.65050278 |
88 | adult heart development (GO:0007512) | 3.61992524 |
89 | muscle cell fate commitment (GO:0042693) | 3.58127882 |
90 | relaxation of cardiac muscle (GO:0055119) | 3.54134676 |
91 | oxidative phosphorylation (GO:0006119) | 3.53594625 |
92 | heart trabecula formation (GO:0060347) | 3.53546232 |
93 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.53315547 |
94 | NADH metabolic process (GO:0006734) | 3.51039049 |
95 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.47252899 |
96 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.46976386 |
97 | positive regulation of cation channel activity (GO:2001259) | 3.43873994 |
98 | response to activity (GO:0014823) | 3.40926291 |
99 | regulation of sequestering of triglyceride (GO:0010889) | 3.40790843 |
100 | respiratory electron transport chain (GO:0022904) | 3.40457962 |
101 | regulation of muscle system process (GO:0090257) | 3.39892096 |
102 | succinate metabolic process (GO:0006105) | 3.39744603 |
103 | cell communication involved in cardiac conduction (GO:0086065) | 3.38685270 |
104 | muscle cell development (GO:0055001) | 3.38664415 |
105 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.37959938 |
106 | negative regulation of muscle hypertrophy (GO:0014741) | 3.36755524 |
107 | myotube differentiation (GO:0014902) | 3.35315654 |
108 | * glycogen metabolic process (GO:0005977) | 3.34641839 |
109 | cardiac muscle adaptation (GO:0014887) | 3.34629538 |
110 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.34629538 |
111 | muscle hypertrophy in response to stress (GO:0003299) | 3.34629538 |
112 | gluconeogenesis (GO:0006094) | 3.33952224 |
113 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.32778571 |
114 | positive regulation of myotube differentiation (GO:0010831) | 3.32290261 |
115 | fructose metabolic process (GO:0006000) | 3.31425592 |
116 | electron transport chain (GO:0022900) | 3.29549778 |
117 | muscle cell cellular homeostasis (GO:0046716) | 3.29396114 |
118 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.28801193 |
119 | response to caffeine (GO:0031000) | 3.28684036 |
120 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.27862619 |
121 | * glucan metabolic process (GO:0044042) | 3.27781931 |
122 | * cellular glucan metabolic process (GO:0006073) | 3.27781931 |
123 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.27745476 |
124 | regulation of myoblast differentiation (GO:0045661) | 3.25343718 |
125 | striated muscle tissue development (GO:0014706) | 3.24913642 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.24680758 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.09070911 |
3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.21179069 |
4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.07131712 |
5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.95387571 |
6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.69910233 |
7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.69910233 |
8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.59402523 |
9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.97934551 |
10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.90126619 |
11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.65588398 |
12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.61127576 |
13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.51847101 |
14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.48681312 |
15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46851941 |
16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.30724822 |
17 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.08052148 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92370528 |
19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86909808 |
20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83037184 |
21 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.82978823 |
22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.81121147 |
23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.76751227 |
24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76426619 |
25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.72460099 |
26 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.67715237 |
27 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.67520973 |
28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.64128609 |
29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60682084 |
30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57113703 |
31 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.53600620 |
32 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.50616371 |
33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42535894 |
34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38193776 |
35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.38115261 |
36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37763215 |
37 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.36993582 |
38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.36678160 |
39 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.32065941 |
40 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21919404 |
41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20471764 |
42 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.20106431 |
43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19736795 |
44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19606508 |
45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19587493 |
46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18604711 |
47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17262522 |
48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15625323 |
49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14642532 |
50 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14481676 |
51 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14347848 |
52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13670164 |
53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13595714 |
54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11357906 |
55 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11123166 |
56 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.10461506 |
57 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08865787 |
58 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08238153 |
59 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08227107 |
60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07608017 |
61 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06071976 |
62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04686132 |
63 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04637428 |
64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04214064 |
65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02885226 |
66 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02558053 |
67 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01269199 |
68 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99062820 |
69 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98625088 |
70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98223723 |
71 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.97421434 |
72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96841899 |
73 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96620949 |
74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96390530 |
75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95538315 |
76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93562500 |
77 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93067138 |
78 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92844347 |
79 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.90421236 |
80 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89995321 |
81 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89995321 |
82 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.89719680 |
83 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.88833838 |
84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88669915 |
85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86664089 |
86 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.86635717 |
87 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85759850 |
88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85548520 |
89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85502719 |
90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84263569 |
91 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84021266 |
92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83417150 |
93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82677668 |
94 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.82658719 |
95 | ATF3_27146783_Chip-Seq_COLON_Human | 0.82653034 |
96 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.82621265 |
97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.82371866 |
98 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82324816 |
99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82212850 |
100 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82205269 |
101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81867346 |
102 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81511617 |
103 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81503796 |
104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80577634 |
105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.80493340 |
106 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.79935788 |
107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79802211 |
108 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.78783677 |
109 | CBP_21632823_ChIP-Seq_H3396_Human | 0.78717864 |
110 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.78700645 |
111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78645035 |
112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78092939 |
113 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.77709765 |
114 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.77576686 |
115 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.77471460 |
116 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.77249543 |
117 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.76729047 |
118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75686792 |
119 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.75409598 |
120 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.75148407 |
121 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.75148407 |
122 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.74928560 |
123 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74446637 |
124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.74214489 |
125 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.74199850 |
126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.73919837 |
127 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.73637779 |
128 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.73250068 |
129 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72970507 |
130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72960634 |
131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.72618913 |
132 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.72588028 |
133 | NFYB_21822215_ChIP-Seq_K562_Human | 0.72114273 |
134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.71989129 |
135 | TBL1_22424771_ChIP-Seq_293T_Human | 0.71946081 |
136 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.71736182 |
137 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.71632708 |
138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71593246 |
139 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.70971484 |
140 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.70348456 |
141 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.70111309 |
142 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.69803654 |
143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.69651412 |
144 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.69567991 |
145 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.69447837 |
146 | P68_20966046_ChIP-Seq_HELA_Human | 0.69331982 |
147 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.68198562 |
148 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.67527124 |
149 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67424997 |
150 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.66509436 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 6.32579085 |
2 | MP0000751_myopathy | 5.57189629 |
3 | MP0004145_abnormal_muscle_electrophysio | 5.51104147 |
4 | MP0000749_muscle_degeneration | 5.34942368 |
5 | MP0002837_dystrophic_cardiac_calcinosis | 5.25986158 |
6 | MP0004036_abnormal_muscle_relaxation | 4.37270178 |
7 | MP0004084_abnormal_cardiac_muscle | 4.12710629 |
8 | MP0004215_abnormal_myocardial_fiber | 3.63483198 |
9 | MP0002106_abnormal_muscle_physiology | 3.57415346 |
10 | MP0004087_abnormal_muscle_fiber | 3.46081462 |
11 | MP0000747_muscle_weakness | 3.32477567 |
12 | MP0005330_cardiomyopathy | 3.22652424 |
13 | MP0000750_abnormal_muscle_regeneration | 3.13412006 |
14 | MP0005620_abnormal_muscle_contractility | 3.12691463 |
15 | MP0002269_muscular_atrophy | 3.10367362 |
16 | MP0000759_abnormal_skeletal_muscle | 2.99201852 |
17 | MP0005369_muscle_phenotype | 2.91892312 |
18 | * MP0004130_abnormal_muscle_cell | 2.88758153 |
19 | MP0002972_abnormal_cardiac_muscle | 2.42261157 |
20 | MP0004484_altered_response_of | 2.34691316 |
21 | MP0004233_abnormal_muscle_weight | 2.25935455 |
22 | MP0008775_abnormal_heart_ventricle | 2.16554691 |
23 | MP0010630_abnormal_cardiac_muscle | 2.11013118 |
24 | MP0006036_abnormal_mitochondrial_physio | 2.05844671 |
25 | MP0003137_abnormal_impulse_conducting | 2.00854273 |
26 | MP0002332_abnormal_exercise_endurance | 1.95892238 |
27 | MP0005385_cardiovascular_system_phenoty | 1.93454840 |
28 | MP0001544_abnormal_cardiovascular_syste | 1.93454840 |
29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.81716538 |
30 | MP0004510_myositis | 1.69050346 |
31 | MP0005666_abnormal_adipose_tissue | 1.50565810 |
32 | MP0000733_abnormal_muscle_development | 1.47368271 |
33 | MP0002108_abnormal_muscle_morphology | 1.47300952 |
34 | MP0006138_congestive_heart_failure | 1.43218164 |
35 | MP0003950_abnormal_plasma_membrane | 1.41162946 |
36 | MP0004185_abnormal_adipocyte_glucose | 1.40197249 |
37 | MP0001661_extended_life_span | 1.40197154 |
38 | MP0004085_abnormal_heartbeat | 1.38318535 |
39 | MP0003828_pulmonary_edema | 1.38125780 |
40 | MP0002127_abnormal_cardiovascular_syste | 1.28054074 |
41 | MP0006035_abnormal_mitochondrial_morpho | 1.22357787 |
42 | MP0005375_adipose_tissue_phenotype | 1.04284348 |
43 | MP0002971_abnormal_brown_adipose | 1.01774830 |
44 | MP0005670_abnormal_white_adipose | 1.00697214 |
45 | MP0005266_abnormal_metabolism | 1.00097175 |
46 | MP0000343_altered_response_to | 0.98367751 |
47 | MP0003806_abnormal_nucleotide_metabolis | 0.94501167 |
48 | MP0000266_abnormal_heart_morphology | 0.92232971 |
49 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90020113 |
50 | MP0002822_catalepsy | 0.83637446 |
51 | MP0000013_abnormal_adipose_tissue | 0.83030928 |
52 | MP0002234_abnormal_pharynx_morphology | 0.82291749 |
53 | MP0004043_abnormal_pH_regulation | 0.80918895 |
54 | MP0005165_increased_susceptibility_to | 0.78883557 |
55 | MP0004147_increased_porphyrin_level | 0.74431738 |
56 | MP0003705_abnormal_hypodermis_morpholog | 0.64900448 |
57 | MP0000003_abnormal_adipose_tissue | 0.61335123 |
58 | MP0000230_abnormal_systemic_arterial | 0.59751118 |
59 | MP0005275_abnormal_skin_tensile | 0.58555580 |
60 | MP0003045_fibrosis | 0.57251191 |
61 | * MP0002078_abnormal_glucose_homeostasis | 0.56907033 |
62 | MP0008961_abnormal_basal_metabolism | 0.55402670 |
63 | MP0002128_abnormal_blood_circulation | 0.52943153 |
64 | MP0004142_abnormal_muscle_tone | 0.48679386 |
65 | MP0003879_abnormal_hair_cell | 0.46015903 |
66 | MP0010368_abnormal_lymphatic_system | 0.45468805 |
67 | MP0005319_abnormal_enzyme/_coenzyme | 0.44320629 |
68 | MP0001299_abnormal_eye_distance/ | 0.42985792 |
69 | MP0003656_abnormal_erythrocyte_physiolo | 0.42667753 |
70 | MP0004270_analgesia | 0.41584085 |
71 | MP0002638_abnormal_pupillary_reflex | 0.40549292 |
72 | MP0001879_abnormal_lymphatic_vessel | 0.38777235 |
73 | * MP0005334_abnormal_fat_pad | 0.37318462 |
74 | MP0005535_abnormal_body_temperature | 0.36505991 |
75 | MP0005187_abnormal_penis_morphology | 0.35394129 |
76 | MP0003279_aneurysm | 0.35165429 |
77 | MP0003566_abnormal_cell_adhesion | 0.34297027 |
78 | MP0005167_abnormal_blood-brain_barrier | 0.34280094 |
79 | MP0008438_abnormal_cutaneous_collagen | 0.33040863 |
80 | MP0005083_abnormal_biliary_tract | 0.32380695 |
81 | MP0003195_calcinosis | 0.31191796 |
82 | MP0002909_abnormal_adrenal_gland | 0.30488510 |
83 | MP0003948_abnormal_gas_homeostasis | 0.30377699 |
84 | MP0002114_abnormal_axial_skeleton | 0.30323255 |
85 | MP0002118_abnormal_lipid_homeostasis | 0.29765252 |
86 | MP0009115_abnormal_fat_cell | 0.28950181 |
87 | MP0005451_abnormal_body_composition | 0.26640430 |
88 | MP0009780_abnormal_chondrocyte_physiolo | 0.26037089 |
89 | * MP0005452_abnormal_adipose_tissue | 0.25882592 |
90 | MP0002925_abnormal_cardiovascular_devel | 0.25820156 |
91 | MP0005166_decreased_susceptibility_to | 0.25556828 |
92 | MP0000762_abnormal_tongue_morphology | 0.25084979 |
93 | MP0001853_heart_inflammation | 0.24556831 |
94 | MP0010030_abnormal_orbit_morphology | 0.24308158 |
95 | MP0000372_irregular_coat_pigmentation | 0.23915230 |
96 | MP0003959_abnormal_lean_body | 0.23380127 |
97 | MP0005623_abnormal_meninges_morphology | 0.23264307 |
98 | MP0000767_abnormal_smooth_muscle | 0.22872703 |
99 | MP0005423_abnormal_somatic_nervous | 0.22550128 |
100 | MP0003941_abnormal_skin_development | 0.22094023 |
101 | MP0002896_abnormal_bone_mineralization | 0.21965387 |
102 | MP0004134_abnormal_chest_morphology | 0.21717911 |
103 | MP0008569_lethality_at_weaning | 0.21452780 |
104 | MP0000579_abnormal_nail_morphology | 0.21363392 |
105 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.21325262 |
106 | MP0006276_abnormal_autonomic_nervous | 0.21186945 |
107 | MP0002734_abnormal_mechanical_nocicepti | 0.21059879 |
108 | MP0001984_abnormal_olfaction | 0.20940719 |
109 | MP0001784_abnormal_fluid_regulation | 0.20458852 |
110 | MP0005376_homeostasis/metabolism_phenot | 0.20431801 |
111 | MP0001614_abnormal_blood_vessel | 0.20243865 |
112 | MP0001943_abnormal_respiration | 0.19846653 |
113 | MP0009250_abnormal_appendicular_skeleto | 0.19254909 |
114 | MP0009672_abnormal_birth_weight | 0.19215510 |
115 | MP0004924_abnormal_behavior | 0.18875657 |
116 | MP0005386_behavior/neurological_phenoty | 0.18875657 |
117 | MP0002066_abnormal_motor_capabilities/c | 0.18610091 |
118 | MP0009384_cardiac_valve_regurgitation | 0.18460900 |
119 | MP0005332_abnormal_amino_acid | 0.17795667 |
120 | MP0001346_abnormal_lacrimal_gland | 0.12451956 |
121 | MP0002168_other_aberrant_phenotype | 0.12380601 |
122 | MP0008874_decreased_physiological_sensi | 0.11368333 |
123 | MP0004197_abnormal_fetal_growth/weight/ | 0.11320524 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 8.20420351 |
2 | Exercise-induced muscle cramps (HP:0003710) | 7.72781602 |
3 | Muscle fiber inclusion bodies (HP:0100299) | 7.37264084 |
4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.16274051 |
5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.15889736 |
6 | Calf muscle hypertrophy (HP:0008981) | 6.92385909 |
7 | Nemaline bodies (HP:0003798) | 6.49173713 |
8 | Myoglobinuria (HP:0002913) | 5.92319344 |
9 | Muscle fiber splitting (HP:0003555) | 5.78959129 |
10 | Sudden death (HP:0001699) | 5.72916702 |
11 | Type 1 muscle fiber predominance (HP:0003803) | 5.44334664 |
12 | Distal arthrogryposis (HP:0005684) | 5.28861266 |
13 | Hyporeflexia of lower limbs (HP:0002600) | 5.23299628 |
14 | Difficulty running (HP:0009046) | 5.07854794 |
15 | Abnormality of the calf musculature (HP:0001430) | 5.05886093 |
16 | Rhabdomyolysis (HP:0003201) | 4.77274899 |
17 | EMG: myopathic abnormalities (HP:0003458) | 4.68376026 |
18 | Myopathic facies (HP:0002058) | 4.59678502 |
19 | Ventricular tachycardia (HP:0004756) | 4.59408439 |
20 | Increased connective tissue (HP:0009025) | 4.42805063 |
21 | Round ear (HP:0100830) | 4.41696359 |
22 | Muscle stiffness (HP:0003552) | 4.25539644 |
23 | Subaortic stenosis (HP:0001682) | 4.16190260 |
24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.16190260 |
25 | Myotonia (HP:0002486) | 4.08940991 |
26 | Ulnar deviation of the wrist (HP:0003049) | 4.07683692 |
27 | Atrial fibrillation (HP:0005110) | 3.58718297 |
28 | Lipoatrophy (HP:0100578) | 3.50855941 |
29 | Asymmetric septal hypertrophy (HP:0001670) | 3.47100276 |
30 | Calcaneovalgus deformity (HP:0001848) | 3.42907155 |
31 | Rimmed vacuoles (HP:0003805) | 3.36843450 |
32 | Difficulty climbing stairs (HP:0003551) | 3.36388043 |
33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.34849149 |
34 | Primary atrial arrhythmia (HP:0001692) | 3.34291082 |
35 | Right ventricular cardiomyopathy (HP:0011663) | 3.32986639 |
36 | Neck muscle weakness (HP:0000467) | 3.25017929 |
37 | Absent phalangeal crease (HP:0006109) | 3.24902359 |
38 | Increased variability in muscle fiber diameter (HP:0003557) | 3.23424086 |
39 | Supraventricular tachycardia (HP:0004755) | 3.22203670 |
40 | Areflexia of lower limbs (HP:0002522) | 3.15137778 |
41 | Supraventricular arrhythmia (HP:0005115) | 3.14664476 |
42 | Dilated cardiomyopathy (HP:0001644) | 3.09833614 |
43 | Deformed tarsal bones (HP:0008119) | 3.07198316 |
44 | Bundle branch block (HP:0011710) | 3.03952441 |
45 | Syncope (HP:0001279) | 2.95013244 |
46 | Palpitations (HP:0001962) | 2.82430770 |
47 | Distal lower limb muscle weakness (HP:0009053) | 2.70969349 |
48 | Ventricular arrhythmia (HP:0004308) | 2.69586716 |
49 | Abnormal finger flexion creases (HP:0006143) | 2.67522843 |
50 | Hypoplastic ischia (HP:0003175) | 2.64051803 |
51 | Prolonged QT interval (HP:0001657) | 2.60906742 |
52 | Frequent falls (HP:0002359) | 2.60870568 |
53 | Heart block (HP:0012722) | 2.51737629 |
54 | Fetal akinesia sequence (HP:0001989) | 2.51319274 |
55 | Muscular dystrophy (HP:0003560) | 2.46743739 |
56 | Malignant hyperthermia (HP:0002047) | 2.39661846 |
57 | Abnormal atrioventricular conduction (HP:0005150) | 2.37241939 |
58 | Hyperkalemia (HP:0002153) | 2.36946226 |
59 | EMG: neuropathic changes (HP:0003445) | 2.34458889 |
60 | Abnormality of the ischium (HP:0003174) | 2.32534312 |
61 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.32008235 |
62 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.32008235 |
63 | Generalized muscle weakness (HP:0003324) | 2.29151073 |
64 | Facial diplegia (HP:0001349) | 2.28388322 |
65 | Pelvic girdle muscle weakness (HP:0003749) | 2.27293487 |
66 | Shoulder girdle muscle weakness (HP:0003547) | 2.25176619 |
67 | Hip contracture (HP:0003273) | 2.24755193 |
68 | Abnormality of the foot musculature (HP:0001436) | 2.20146109 |
69 | Limb-girdle muscle atrophy (HP:0003797) | 2.19381959 |
70 | Weak cry (HP:0001612) | 2.18252027 |
71 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.17924139 |
72 | Proximal amyotrophy (HP:0007126) | 2.16942042 |
73 | Atrioventricular block (HP:0001678) | 2.14655223 |
74 | Gowers sign (HP:0003391) | 2.13966720 |
75 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.10847312 |
76 | Ketoacidosis (HP:0001993) | 2.10200948 |
77 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.09887641 |
78 | Abnormality of alanine metabolism (HP:0010916) | 2.09887641 |
79 | Hyperalaninemia (HP:0003348) | 2.09887641 |
80 | Waddling gait (HP:0002515) | 2.07830351 |
81 | Hepatic necrosis (HP:0002605) | 2.06916572 |
82 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06014651 |
83 | Scapular winging (HP:0003691) | 2.04866241 |
84 | Limb-girdle muscle weakness (HP:0003325) | 2.04732299 |
85 | Foot dorsiflexor weakness (HP:0009027) | 2.04218820 |
86 | Distal lower limb amyotrophy (HP:0008944) | 2.01706974 |
87 | Acute necrotizing encephalopathy (HP:0006965) | 2.00979738 |
88 | Left ventricular hypertrophy (HP:0001712) | 2.00027209 |
89 | Progressive muscle weakness (HP:0003323) | 1.97222556 |
90 | Ventricular fibrillation (HP:0001663) | 1.95514752 |
91 | Hypoglycemic coma (HP:0001325) | 1.95233718 |
92 | Exercise intolerance (HP:0003546) | 1.94931220 |
93 | Abnormality of the calcaneus (HP:0008364) | 1.94097421 |
94 | Abnormality of the neuromuscular junction (HP:0003398) | 1.93785736 |
95 | Fatigable weakness (HP:0003473) | 1.93785736 |
96 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.90717532 |
97 | Lower limb amyotrophy (HP:0007210) | 1.90706503 |
98 | Ragged-red muscle fibers (HP:0003200) | 1.90687869 |
99 | Abnormal EKG (HP:0003115) | 1.90120377 |
100 | Increased muscle lipid content (HP:0009058) | 1.85600503 |
101 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82250704 |
102 | Paralysis (HP:0003470) | 1.81989474 |
103 | Bulbar palsy (HP:0001283) | 1.80037816 |
104 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.79807189 |
105 | Spinal rigidity (HP:0003306) | 1.78515573 |
106 | Hepatocellular necrosis (HP:0001404) | 1.75439594 |
107 | Acute encephalopathy (HP:0006846) | 1.75343325 |
108 | Metatarsus adductus (HP:0001840) | 1.74333116 |
109 | Long clavicles (HP:0000890) | 1.74079830 |
110 | Slender build (HP:0001533) | 1.72720805 |
111 | Palmoplantar keratoderma (HP:0000982) | 1.72327006 |
112 | Steppage gait (HP:0003376) | 1.70573619 |
113 | Ulnar deviation of finger (HP:0009465) | 1.66304027 |
114 | Nonprogressive disorder (HP:0003680) | 1.61607931 |
115 | Limited hip movement (HP:0008800) | 1.54591823 |
116 | Diaphragmatic weakness (HP:0009113) | 1.52305819 |
117 | Increased intramyocellular lipid droplets (HP:0012240) | 1.51539552 |
118 | Type 2 muscle fiber atrophy (HP:0003554) | 1.46865782 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 7.63966040 |
2 | TTN | 6.16819194 |
3 | PHKG1 | 5.20618352 |
4 | PHKG2 | 5.20618352 |
5 | PDK3 | 3.30461036 |
6 | PDK4 | 3.30461036 |
7 | NEK1 | 2.57850401 |
8 | DMPK | 2.47880838 |
9 | NME1 | 2.45745853 |
10 | PINK1 | 2.25229924 |
11 | TRIB3 | 2.15929367 |
12 | PDK2 | 2.13249222 |
13 | PIK3CG | 2.11298638 |
14 | PIK3CA | 2.04504695 |
15 | BCKDK | 2.02727687 |
16 | MAP2K3 | 1.96313073 |
17 | PKN2 | 1.91358434 |
18 | LMTK2 | 1.80785613 |
19 | MAP3K7 | 1.80262214 |
20 | STK24 | 1.64695188 |
21 | MUSK | 1.61587594 |
22 | MYLK | 1.37121159 |
23 | MAPK12 | 1.34652190 |
24 | TIE1 | 1.19931861 |
25 | ZAK | 1.17282304 |
26 | GRK7 | 1.13937930 |
27 | MARK1 | 1.11366007 |
28 | PRKAA2 | 1.02655052 |
29 | MAP2K4 | 1.01249990 |
30 | NEK9 | 0.98855962 |
31 | PRKAA1 | 0.97726338 |
32 | INSRR | 0.95400749 |
33 | CCNB1 | 0.93880171 |
34 | EEF2K | 0.89831701 |
35 | TRPM7 | 0.89372612 |
36 | ILK | 0.81399555 |
37 | CAMK2D | 0.79441698 |
38 | MAP2K6 | 0.79023362 |
39 | MAP3K3 | 0.72827117 |
40 | MAPKAPK3 | 0.71728296 |
41 | PRKD1 | 0.70764256 |
42 | MOS | 0.67997830 |
43 | RIPK1 | 0.53842424 |
44 | ROCK1 | 0.51392544 |
45 | CAMK2G | 0.51075158 |
46 | FLT3 | 0.50029112 |
47 | PKN1 | 0.49982852 |
48 | MAP3K5 | 0.49583438 |
49 | PAK3 | 0.49427226 |
50 | AKT2 | 0.49139378 |
51 | MAP3K13 | 0.49046380 |
52 | DYRK1B | 0.48249277 |
53 | CAMK4 | 0.45661921 |
54 | SIK1 | 0.43128165 |
55 | CAMK2B | 0.43120397 |
56 | EPHB1 | 0.41424760 |
57 | PRKACB | 0.38973897 |
58 | MAPK11 | 0.38455803 |
59 | STK38L | 0.38421278 |
60 | SGK2 | 0.36664830 |
61 | WNK1 | 0.36434376 |
62 | ERBB3 | 0.34808857 |
63 | PTK6 | 0.33374929 |
64 | PDGFRA | 0.32690027 |
65 | PDPK1 | 0.31397538 |
66 | CAMK2A | 0.31091232 |
67 | TAOK2 | 0.29619822 |
68 | PDK1 | 0.29529741 |
69 | LATS1 | 0.29356724 |
70 | TGFBR2 | 0.28828370 |
71 | LIMK1 | 0.28690055 |
72 | * PRKACA | 0.27977245 |
73 | SGK1 | 0.27776153 |
74 | CAMK1 | 0.27325596 |
75 | WNK4 | 0.25924573 |
76 | PRKG1 | 0.25291062 |
77 | EPHA3 | 0.24329294 |
78 | STK38 | 0.23541995 |
79 | RPS6KB1 | 0.23188838 |
80 | MAP3K11 | 0.22583258 |
81 | MAPK10 | 0.21949676 |
82 | ROCK2 | 0.21190542 |
83 | MAPK7 | 0.20883031 |
84 | TBK1 | 0.20692738 |
85 | STK4 | 0.20576419 |
86 | STK11 | 0.19129957 |
87 | MARK3 | 0.18806778 |
88 | MAPK13 | 0.18604243 |
89 | NLK | 0.17866037 |
90 | TAOK1 | 0.17321276 |
91 | * PRKACG | 0.16774430 |
92 | CDC42BPA | 0.16751814 |
93 | MARK2 | 0.16645700 |
94 | * RPS6KA3 | 0.15944089 |
95 | MAP3K6 | 0.15298242 |
96 | KDR | 0.15221939 |
97 | RET | 0.15108782 |
98 | SGK223 | 0.15034507 |
99 | SGK494 | 0.15034507 |
100 | SGK3 | 0.14877210 |
101 | ZAP70 | 0.13406901 |
102 | STK39 | 0.13267022 |
103 | MAP3K1 | 0.13233046 |
104 | LATS2 | 0.13002889 |
105 | RAF1 | 0.12915806 |
106 | RPS6KB2 | 0.12763549 |
107 | FGFR3 | 0.12592794 |
108 | RPS6KA6 | 0.11146618 |
109 | JAK1 | 0.10753444 |
110 | KSR2 | 0.10174568 |
111 | PTK2B | 0.10114822 |
112 | LRRK2 | 0.09435719 |
113 | PRKCH | 0.09359333 |
114 | ICK | 0.08114750 |
115 | RPS6KC1 | 0.07834182 |
116 | RPS6KL1 | 0.07834182 |
117 | CAMK1G | 0.07828625 |
118 | MTOR | 0.07819830 |
119 | JAK2 | 0.07443884 |
120 | MAPK4 | 0.07234794 |
121 | MAP3K10 | 0.06877556 |
122 | MAP2K1 | 0.06457519 |
123 | PAK6 | 0.05966484 |
124 | DAPK2 | 0.05090058 |
125 | KSR1 | 0.04207113 |
126 | PRKG2 | 0.03528044 |
127 | PRPF4B | 0.03382514 |
128 | PRKDC | 0.02710461 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.71128110 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.04183024 |
3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.85870654 |
4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.85312455 |
5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.57118597 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.34378594 |
7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.10091092 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81683851 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69634483 |
10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.54598280 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.50446909 |
12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.36913847 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32600555 |
14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.03119037 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.02671654 |
16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.91698633 |
17 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.87838395 |
18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81412035 |
19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70046680 |
20 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.61915999 |
21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.60187349 |
22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51914251 |
23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.42501740 |
24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41555339 |
25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.38572115 |
26 | * Insulin resistance_Homo sapiens_hsa04931 | 1.37023120 |
27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34018512 |
28 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.33913818 |
29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.25855821 |
30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23914377 |
31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.20446781 |
32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.19473605 |
33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.19398242 |
34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11865001 |
35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06052260 |
36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05376597 |
37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00556685 |
38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.99067603 |
39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93743670 |
40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92422496 |
41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89329108 |
42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83696953 |
43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77549891 |
44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77469364 |
45 | Focal adhesion_Homo sapiens_hsa04510 | 0.76458417 |
46 | Tight junction_Homo sapiens_hsa04530 | 0.73950613 |
47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73896465 |
48 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72691938 |
49 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68240198 |
50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65231467 |
51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64540365 |
52 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63597003 |
53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61391528 |
54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60136645 |
55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59580270 |
56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58591158 |
57 | Renin secretion_Homo sapiens_hsa04924 | 0.56826887 |
58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56744644 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.51599211 |
60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48379883 |
61 | Salivary secretion_Homo sapiens_hsa04970 | 0.47192794 |
62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46062396 |
63 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45741377 |
64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44564479 |
65 | Peroxisome_Homo sapiens_hsa04146 | 0.41867972 |
66 | Insulin secretion_Homo sapiens_hsa04911 | 0.41246693 |
67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40348594 |
68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39141990 |
69 | Adherens junction_Homo sapiens_hsa04520 | 0.39104073 |
70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37777936 |
71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35326187 |
72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35312107 |
73 | Long-term depression_Homo sapiens_hsa04730 | 0.34411658 |
74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34317831 |
75 | Platelet activation_Homo sapiens_hsa04611 | 0.30085263 |
76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29523362 |
77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29180555 |
78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28964734 |
79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28772835 |
80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28678670 |
81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27918259 |
82 | Amoebiasis_Homo sapiens_hsa05146 | 0.24322485 |
83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23482397 |
84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22574888 |
85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21173252 |
86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.20369526 |
87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.20348325 |
88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20206074 |
89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.19944329 |
90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19643852 |
91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19642784 |
92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.19522610 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19319307 |
94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18335923 |
95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18087488 |
96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17731872 |
97 | Glioma_Homo sapiens_hsa05214 | 0.16790761 |
98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.16591708 |
99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.14385423 |
100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.13593814 |
101 | Purine metabolism_Homo sapiens_hsa00230 | 0.13020492 |
102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.11106399 |
103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.10693395 |
104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.08115286 |
105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.07956333 |
106 | ABC transporters_Homo sapiens_hsa02010 | 0.05047284 |
107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.04824275 |
108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.03485863 |
109 | Bile secretion_Homo sapiens_hsa04976 | 0.02539495 |
110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.01386365 |
111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.00414237 |
112 | Olfactory transduction_Homo sapiens_hsa04740 | -0.0196216 |
113 | Gap junction_Homo sapiens_hsa04540 | -0.0176151 |
114 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0085075 |
115 | Sulfur metabolism_Homo sapiens_hsa00920 | -0.0038371 |